Novartis Loses Bid to Sell Copies of Abbott’s Biaxin XL Drug (Bloomberg)
October 24th, 2008 Posted in Abbott LaboratoriesOct. 21 (Bloomberg) — Novartis AG ’s Sandoz unit lost its bid to begin selling generic versions of the Abbott Laboratories antibiotic Biaxin XL before a trial on a patent dispute over the medicine.